RESUMO
Antibiotic resistance is a continuously increasing concern for public healthcare. Understanding resistance mechanisms and their emergence is crucial for the development of new antibiotics and their effective use. The peptide antibiotic albicidin is such a promising candidate that, as a gyrase poison, shows bactericidal activity against a wide range of gram-positive and gram-negative bacteria. Here, we report the discovery of a gene amplification-based mechanism that imparts an up to 1000-fold increase in resistance levels against albicidin. RNA sequencing and proteomics data show that this novel mechanism protects Salmonella Typhimurium and Escherichia coli by increasing the copy number of STM3175 (YgiV), a transcription regulator with a GyrI-like small molecule binding domain that traps albicidin with high affinity. X-ray crystallography and molecular docking reveal a new conserved motif in the binding groove of the GyrI-like domain that can interact with aromatic building blocks of albicidin. Phylogenetic studies suggest that this resistance mechanism is ubiquitous in gram-negative bacteria, and our experiments confirm that STM3175 homologs can confer resistance in pathogens such as Vibrio vulnificus and Pseudomonas aeruginosa.
Assuntos
Antibacterianos , Amplificação de Genes , Antibacterianos/farmacologia , Simulação de Acoplamento Molecular , Filogenia , Bactérias Gram-Negativas/genética , Bactérias Gram-Positivas/metabolismoRESUMO
Here, we report the draft genome sequences of Lactiplantibacillus plantarum strains DSMZ 8862 and DSMZ 8866, which are currently being used as authorized feed additives in the European Union under regulation (EC) number 1831/2003. The draft genome sequences contain 3,334 kbp (DSMZ 8862) and 2,992 kbp (DSMZ 8866) in 15 and 8 contigs, respectively.